Description

Travinor (travoprost) Eye Drops Solution 0.040 mg/ml. 2.5 ml Vial

Ingredients

Travinor contains travoprost as the active ingredient at a concentration of 0.040 mg/ml. Other ingredients include benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, and water for injections.

Dosage

The recommended dosage is one drop in the affected eye(s) once daily in the evening. Do not exceed the prescribed dose as it may increase the risk of side effects.

Indications

Travinor is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications

Do not use Travinor if you are allergic to travoprost or any other ingredients in the formulation. It is also contraindicated in patients with macular edema.

Directions

Before using Travinor, wash your hands and tilt your head back. Pull down the lower eyelid to create a small pocket and instill the prescribed number of drops. Close your eyes for a few minutes without blinking.

Scientific Evidence

Travoprost, the active ingredient in Travinor, is a prostaglandin analog that works by increasing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure. Clinical studies have shown that travoprost is effective in lowering intraocular pressure and is well-tolerated in patients with glaucoma.

Additional Information

It is important to store Travinor at room temperature away from light and moisture. Keep the vial tightly closed when not in use. Contact your healthcare provider if you experience any eye irritation, redness, or changes in vision while using this medication.

Travinor (travoprost) eye drops offer a convenient and effective treatment option for individuals with glaucoma or ocular hypertension. By reducing intraocular pressure, Travinor helps to prevent optic nerve damage and vision loss associated with these conditions.

Studies have demonstrated the efficacy of travoprost in managing intraocular pressure, with many patients experiencing a significant reduction in eye pressure levels. The safety profile of Travinor has also been well-established through clinical trials, making it a trusted choice for glaucoma management.